Syros Pharmaceuticals Pink Sheet Forward View - Accumulation Distribution
| SYRS Stock | USD 0.0008 0.0003 60.00% |
Syros Pink Sheet outlook is based on your current time horizon.
At this time, The relative strength index (RSI) of Syros Pharmaceuticals' share price is at 53. This usually implies that the pink sheet is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Syros Pharmaceuticals, making its price go up or down. Momentum 53
Impartial
Oversold | Overbought |
Using Syros Pharmaceuticals hype-based prediction, you can estimate the value of Syros Pharmaceuticals from the perspective of Syros Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
Syros Pharmaceuticals after-hype prediction price | USD 7.67E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Syros |
Syros Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Syros price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Syros using various technical indicators. When you analyze Syros charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Syros Pharmaceuticals Volatility | Backtest Syros Pharmaceuticals | Information Ratio |
Syros Pharmaceuticals Trading Date Momentum
| On February 05 2026 Syros Pharmaceuticals was traded for 0.0008 at the closing time. The top price for the day was 0.0008 and the lowest listed price was 0.0008 . There was no trading activity during the period 0.0. Lack of trading volume on February 5, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Syros Pharmaceuticals to competition |
Other Forecasting Options for Syros Pharmaceuticals
For every potential investor in Syros, whether a beginner or expert, Syros Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Syros Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Syros. Basic forecasting techniques help filter out the noise by identifying Syros Pharmaceuticals' price trends.Syros Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Syros Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Syros Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Syros Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Syros Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Syros Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Syros Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Syros Pharmaceuticals pink sheet market strength indicators, traders can identify Syros Pharmaceuticals entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.6 | |||
| Day Median Price | 8.0E-4 | |||
| Day Typical Price | 8.0E-4 | |||
| Price Action Indicator | 1.0E-4 | |||
| Period Momentum Indicator | 3.0E-4 | |||
| Relative Strength Index | 53.93 |
Syros Pharmaceuticals Risk Indicators
The analysis of Syros Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Syros Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting syros pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 58.68 | |||
| Semi Deviation | 30.25 | |||
| Standard Deviation | 89.96 | |||
| Variance | 8092.42 | |||
| Downside Variance | 2638.89 | |||
| Semi Variance | 915.23 | |||
| Expected Short fall | (130.24) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Syros Pharmaceuticals
The number of cover stories for Syros Pharmaceuticals depends on current market conditions and Syros Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Syros Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Syros Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Syros Pharmaceuticals Short Properties
Syros Pharmaceuticals' future price predictability will typically decrease when Syros Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Syros Pharmaceuticals often depends not only on the future outlook of the potential Syros Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Syros Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 28.3 M | |
| Cash And Short Term Investments | 139.5 M |
Additional Tools for Syros Pink Sheet Analysis
When running Syros Pharmaceuticals' price analysis, check to measure Syros Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syros Pharmaceuticals is operating at the current time. Most of Syros Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syros Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syros Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syros Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.